Insulin in Tablets
Validation batches of insulin in tablets production according to a state-of-art technology has been launched in the Orel region at Sanofi-Aventis Vostok site.
During presentation on production of novel insulin Naira Adamyan, general director, Sanofi Group Eurasia told about unique experience of the company in that area. She reported that the next generation insulin developed by Sanofi has a more consistent and stable action profile and less number of side effects, providing more flexibility for use ensuring optimal control of blood glucose level and disease in diabetic patients.
A working meeting of regional head Vadim Potomsky with Sanofi Group management team was held to discuss prospects of cooperation and implementation by the company of its investment projects.